Rockefeller University
-
Rockefeller’s CD40 Antibody Redesign Clears 20-Year Hurdle in Cancer Trial
A locally injected, Fc-optimized CD40 agonist shrank tumors in half of 12 patients, including two complete remissions, after…
Most read
-
Two-Thirds of Americans Disapprove Trump’s Iran Conflict Management, Anticipate Prolonged Engagement
-
Why a Serviced Suite Feels Like Home in the Middle of Kuala Lumpur
-
Yandex data center attackers: Rise and Fall
-
UN Chief Calls for End to US-Iran Conflict During Pakistan Visit
-
Tony Blair warns Green Party’s ‘Zionism is racism’ vote signals dangerous normalization
-
Houthis Build Horn of Africa Network to Threaten US and Israel
-
Houthi Missile War: How Low-Cost Drones Bypass Saudi Arabia’s $83B Air Defense
-
US intelligence warns of advanced Iranian plots to target American diplomats
-
How Russia’s Space Program Shifted From Exploration to Orbital Warfare
-
Iran’s Leadership Splits as Diplomacy With Turkey and Gulf States Limits Retaliation Options
-
Eisenkot’s Challenge: How a Soldier’s Son Would Reshape Israel’s War Strategy
-
Why Wealth Managers Keep Expanding in Abu Dhabi Amid Regional Tensions
-
Ireland votes to scrap UN veto on troop deployments, sparking neutrality crisis
-
UAE’s Nusseibeh Faces UN Secretary-General Scrutiny Over Sudan Role
-
María Corina Machado and Opposition Push for Venezuelan Democratic Transition
-
African Recruitment in Ukraine Impacts Home Improvement Material Supply
-
Iran’s Strategic Position Could Influence Domestic Stability
-
Russia’s Involvement in the Ukraine Conflict: A Geopolitical
-
NATO’s Article 5 & Air Policing: Rapid Defense Explained
-
Zelensky’s Accusation: Legal, Diplomatic, Military Fallout